Neutrophils: Novel key players in Rheumatoid Arthritis. Current and future therapeutic targets
Open accessThe DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
Abstract
Rheumatoid Arthritis (RA) is a complex systemic autoimmune disease in which various cell types are involved. Among them, neutrophils have been recognized as important players in the onset and the progression of RA. The pathogenic role of neutrophils in RA lies in the alteration of several processes, including increased cell survival and migratory capacity, abnormal inflammatory activity, elevated oxidative stress and an exacerbated release of neutrophil extracellular traps. Through these mechanisms, neutrophils can activate other immune cells, thus perpetuating inflammation and leading to the destruction of the cartilage and bone of the affected joint. Given the considerable contribution of neutrophils to the pathophysiology of RA, several studies have attempted to clarify the effects of various therapeutic agents on this subtype of leukocyte. To date, recent studies have envisaged the role of new molecules on the pathogenic profile of neutrophils in RA, which could represent novel targets in future therapies. In this review, we aim to review the pathogenic role of neutrophils in RA, the effect of conventional treatments and biologic therapies, and the new, potential targets of neutrophil-derived molecules for the treatment of RA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.015 · Cited by 3,710
Novel cell death program leads to neutrophil extracellular traps
Fuchs, T. A., Abed, U., Goosmann, C., Hurwitz, R., Schulze, I., Wahn, V., Weinrauch, Y., Brinkmann, V., & Zychlinsky, A. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200606027 · Cited by 3,197
Baggiolini, M., Dewald, B., & Moser, B. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.675 · Cited by 2,192
IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex
Kotenko, S. V., Gallagher, G., Baurin, V. V., Lewis-Antes, A., Shen, M., Shah, N. K., Langer, J. A., Sheikh, F., Dickensheets, H., & Donnelly, R. P. (2003) · Nature Immunology · doi:10.1038/ni875 · Cited by 1,868
Inhibition of NF-κB by Sodium Salicylate and Aspirin
Kopp, E., & Ghosh, S. (1994) · Science · doi:10.1126/science.8052854 · Cited by 1,753
IL-28, IL-29 and their class II cytokine receptor IL-28R
Sheppard, P., Kindsvogel, W., Xu, W., Henderson, K., Schlutsmeyer, S., Whitmore, T. E., Kuestner, R., Garrigues, U., Birks, C., Roraback, J., et al. (2003) · Nature Immunology · doi:10.1038/ni873 · Cited by 1,570
Wang, Y., Li, M., Stadler, S., Correll, S., Li, P., Wang, D., Hayama, R., Leonelli, L., Han, H., Grigoryev, S. A., et al. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200806072 · Cited by 1,521
Lam, J., Takeshita, S., Barker, J. E., Kanagawa, O., Ross, F. P., & Teitelbaum, S. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11176 · Cited by 1,440
Khandpur, R., Carmona-Rivera, C., Vivekanandan-Giri, A., Gizinski, A., Yalavarthi, S., Knight, J. S., Friday, S., Li, S., Patel, R. M., Subramanian, V., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005580 · Cited by 1,337
Suzuki, A., Yamada, R., Chang, X., Tokuhiro, S., Sawada, T., Suzuki, M., Nagasaki, M., Nakayama-Hamada, M., Kawaida, R., Ono, M., et al. (2003) · Nature Genetics · doi:10.1038/ng1206 · Cited by 1,168
Saag, K. G., Teng, G. G., Patkar, N. M., Anuntiyo, J., Finney, C., Curtis, J. R., Paulus, H. E., Mudano, A., Pisu, M., Elkins‐Melton, M., et al. (2008) · Arthritis Care & Research · doi:10.1002/art.23721 · Cited by 1,157
Novel treatment strategies in rheumatoid arthritis
Burmester, G. R., & Pope, J. E. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31491-5 · Cited by 1,068
Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
Fleischmann, R., Kremer, J., Cush, J., Schulze-Koops, H., Connell, C. A., Bradley, J. D., Gruben, D., Wallenstein, G. V., Zwillich, S. H., & Kanik, K. S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109071 · Cited by 1,024
Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
van Vollenhoven, R. F., Fleischmann, R., Cohen, S., Lee, E. B., García Meijide, J. A., Wagner, S., Forejtova, S., Zwillich, S. H., Gruben, D., Koncz, T., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112072 · Cited by 945
NADPH oxidases: An overview from structure to innate immunity-associated pathologies
Panday, A., Sahoo, M. K., Osorio, D., & Batra, S. (2015) · Cellular & Molecular Immunology · doi:10.1038/cmi.2014.89 · Cited by 944
Rituximab: Mechanism of Action
Weiner, G. J. (2010) · Seminars in Hematology · doi:10.1053/j.seminhematol.2010.01.011 · Cited by 786
Neutrophil function in inflammation and inflammatory diseases
Wright, H. L., Moots, R. J., Bucknall, R. C., & Edwards, S. W. (2010) · Rheumatology · doi:10.1093/rheumatology/keq045 · Cited by 761
Burmester, G. R., Blanco, R., Charles-Schoeman, C., Wollenhaupt, J., Zerbini, C., Benda, B., Gruben, D., Wallenstein, G., Krishnaswami, S., Zwillich, S. H., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61424-x · Cited by 714
Myeloperoxidase, a Leukocyte-Derived Vascular NO Oxidase
Eiserich, J. P., Baldus, S., Brennan, M.-L., Ma, W., Zhang, C., Tousson, A., Castro, L., Lusis, A. J., Nauseef, W. M., White, C. R., et al. (2002) · Science · doi:10.1126/science.1106830 · Cited by 685
Cronstein, B. N., Naime, D., & Ostad, E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116884 · Cited by 679
Use of NSAIDs in treating patients with arthritis
Crofford, L. J. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4174 · Cited by 650
Neutrophil extracellular traps (NETs) in autoimmune diseases: A comprehensive review
Lee, K. H., Kronbichler, A., Park, D. D.-Y., Park, Y., Moon, H., Kim, H., Choi, J. H., Choi, Y., Shim, S., Lyu, I. S., et al. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.09.012 · Cited by 624
IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G
Lefrançais, E., Roga, S., Gautier, V., Gonzalez-de-Peredo, A., Monsarrat, B., Girard, J.-P., & Cayrol, C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115884109 · Cited by 594
The multifactorial role of neutrophils in rheumatoid arthritis
Wright, H. L., Moots, R. J., & Edwards, S. W. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.80 · Cited by 590
Histone Deimination As a Response to Inflammatory Stimuli in Neutrophils
Neeli, I., Khan, S. N., & Radic, M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1895 · Cited by 565
Kahlenberg, J. M., Carmona-Rivera, C., Smith, C. K., & Kaplan, M. J. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202388 · Cited by 508
Kurowska-Stolarska, M., Kewin, P., Murphy, G., Russo, R. C., Stolarski, B., Garcia, C. C., Komai-Koma, M., Pitman, N., Li, Y., McKenzie, A. N. J., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4780 · Cited by 460
El-Benna, J., Dang, P. M.-C., Gougerot-Pocidalo, M.-A., Marie, J.-C., & Braut-Boucher, F. (2009) · Experimental and Molecular Medicine · doi:10.3858/emm.2009.41.4.058 · Cited by 446
Taylor, P. C., Peters, A. M., Paleolog, E., Chapman, P. T., Elliott, M. J., McCloskey, R., Feldmann, M., & Maini, R. N. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200001)43:1<38::aid-anr6>3.0.co;2-l · Cited by 405
Gong, J.-H., Ratkay, L. G., Waterfield, J. D., & Clark-Lewis, I. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.1.131 · Cited by 375
Hodge, J. A., Kawabata, T. T., Krishnaswami, S., Clark, J. D., Telliez, J., Dowty, M. E., Menon, S. S., Lamba, M., & Zwillich, S. H. (2016) · PubMed · Cited by 374
The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders
Barksby, H. E., Lea, S. R., Preshaw, P. M., & Taylor, J. J. (2007) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2007.03441.x · Cited by 371
Sur Chowdhury, C., Giaglis, S., Walker, U. A., Buser, A., Hahn, S., & Hasler, P. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4579 · Cited by 352
Chalaris, A., Rabe, B., Paliga, K., Lange, H., Laskay, T., Fielding, C. A., Jones, S. A., Rose-John, S., & Scheller, J. (2007) · Blood · doi:10.1182/blood-2007-01-067918 · Cited by 329
Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis.
Griffiths, R. J., Pettipher, E. R., Koch, K., Farrell, C. A., Breslow, R., Conklyn, M. J., Smith, M. A., Hackman, B. C., Wimberly, D. J., & Milici, A. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.2.517 · Cited by 315
One year in review 2021: pathogenesis of rheumatoid arthritis
Testa, D., Calvacchi, S., Petrelli, F., Giannini, D., Bilia, S., Alunno, A., & Puxeddu, I. (2021) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/j1l5l3 · Cited by 314
The mode of action of aspirin-like drugs: effect on inducible nitric oxide synthase.
Amin, A. R., Vyas, P., Attur, M., Leszczynska-Piziak, J., Patel, I. R., Weissmann, G., & Abramson, S. B. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7926 · Cited by 308
Neutrophil-derived leukotriene B4 is required for inflammatory arthritis
Chen, M., Lam, B. K., Kanaoka, Y., Nigrovic, P. A., Audoly, L. P., Austen, K. F., & Lee, D. M. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052371 · Cited by 287
The antiapoptotic protein Mcl-1 is essential for the survival of neutrophils but not macrophages
Dzhagalov, I., St. John, A., & He, Y.-W. (2007) · Blood · doi:10.1182/blood-2006-03-013771 · Cited by 279
Chatzidionysiou, K., Emamikia, S., Nam, J., Ramiro, S., Smolen, J., van der Heijde, D., Dougados, M., Bijlsma, J., Burmester, G., Scholte, M., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210711 · Cited by 278
Kim, N. D., Chou, R. C., Seung, E., Tager, A. M., & Luster, A. D. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052349 · Cited by 273
Protein arginine deiminase 4 (PAD4): Current understanding and future therapeutic potential.
Jones, J. E., Causey, C. P., Knuckley, B., Slack, J. L., & Thompson, P. R. (2009) · PubMed · Cited by 270
IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy
Verri, W. A., Souto, F. O., Vieira, S. M., Almeida, S. C. L., Fukada, S. Y., Xu, D., Alves-Filho, J. C., Cunha, T. M., Guerrero, A. T. G., Mattos-Guimaraes, R. B., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.122655 · Cited by 263
Haringman, J. J., Gerlag, D. M., Smeets, T. J. M., Baeten, D., van den Bosch, F., Bresnihan, B., Breedveld, F. C., Dinant, H. J., Legay, F., Gram, H., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21975 · Cited by 258
Spengler, J., Lugonja, B., Jimmy Ytterberg, A., Zubarev, R. A., Creese, A. J., Pearson, M. J., Grant, M. M., Milward, M., Lundberg, K., Buckley, C. D., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39313 · Cited by 241
Li, H., Hong, S., Qian, J., Zheng, Y., Yang, J., & Yi, Q. (2010) · Blood · doi:10.1182/blood-2009-11-255026 · Cited by 239
Hartl, D., Krauss-Etschmann, S., Koller, B., Hordijk, P. L., Kuijpers, T. W., Hoffmann, F., Hector, A., Eber, E., Marcos, V., Bittmann, I., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.8053 · Cited by 236
Vergunst, C. E., Gerlag, D. M., Lopatinskaya, L., Klareskog, L., Smith, M. D., van den Bosch, F., Dinant, H. J., Lee, Y., Wyant, T., Jacobson, E. W., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23591 · Cited by 236
Nakagawa, M., Terashima, T., D’yachkova, Y., Bondy, G. P., Hogg, J. C., & van Eeden, S. F. (1998) · Circulation · doi:10.1161/01.cir.98.21.2307 · Cited by 235
Myeloperoxidase: A new player in autoimmunity
Strzepa, A., Pritchard, K. A., & Dittel, B. N. (2017) · Cellular Immunology · doi:10.1016/j.cellimm.2017.05.002 · Cited by 234
Maeshima, K., Yamaoka, K., Kubo, S., Nakano, K., Iwata, S., Saito, K., Ohishi, M., Miyahara, H., Tanaka, S., Ishii, K., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34329 · Cited by 233
Mennechet, F. J. D., & Uzé, G. (2006) · Blood · doi:10.1182/blood-2005-10-4129 · Cited by 220
IFN-λ resolves inflammation via suppression of neutrophil infiltration and IL-1β production
Blazek, K., Eames, H. L., Weiss, M., Byrne, A. J., Perocheau, D., Pease, J. E., Doyle, S., McCann, F., Williams, R. O., & Udalova, I. A. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20140995 · Cited by 216
Montesinos, M. C., Desai, A., Delano, D., Chen, J., Fink, J. S., Jacobson, M. A., & Cronstein, B. N. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10712 · Cited by 213
Koltsida, O., Hausding, M., Stavropoulos, A., Koch, S., Tzelepis, G., Übel, C., Kotenko, S. V., Sideras, P., Lehr, H. A., Tepe, M., et al. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100142 · Cited by 207
Regulation of Neutrophil Extracellular Trap Formation by Anti-Inflammatory Drugs
Lapponi, M. J., Carestia, A., Landoni, V. I., Rivadeneyra, L., Etulain, J., Negrotto, S., Pozner, R. G., & Schattner, M. (2013) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.202879 · Cited by 202
Schleimer, R. P., Freeland, H. S., Peters, S. P., Brown, K. E., & Derse, C. P. (1989) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22251-0 · Cited by 193
Methotrexate Suppresses NF-κB Activation Through Inhibition of IκBα Phosphorylation and Degradation
Majumdar, S., & Aggarwal, B. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2911 · Cited by 192
Bone Damage in Rheumatoid Arthritis: Mechanistic Insights and Approaches to Prevention
Karmakar, S., Kay, J., & Gravallese, E. M. (2010) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2010.03.003 · Cited by 186
Effects of IL-6 and IL-6 blockade on neutrophil function in vitro and in vivo
Wright, H. L., Cross, A. L., Edwards, S. W., & Moots, R. J. (2014) · Rheumatology · doi:10.1093/rheumatology/keu035 · Cited by 185
IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice
Verri, W. A., Guerrero, A. T. G., Fukada, S. Y., Valerio, D. A., Cunha, T. M., Xu, D., Ferreira, S. H., Liew, F. Y., & Cunha, F. Q. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712116105 · Cited by 185
Brühl, H., Cihak, J., Schneider, M. A., Plachý, J., Rupp, T., Wenzel, I., Shakarami, M., Milz, S., Ellwart, J. W., Stangassinger, M., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.890 · Cited by 185
Effects of non-steroidal anti-inflammatory agents on human neutrophil functions in vitro and in vivo
Kaplan, H. B., Edelson, H. S., Korchak, H. M., Given, W. P., Abramson, S., & Weissmann, G. (1984) · Biochemical Pharmacology · doi:10.1016/0006-2952(84)90228-4 · Cited by 182
Pillinger, M. H., Capodici, C., Rosenthal, P., Kheterpal, N., Hanft, S., Philips, M. R., & Weissmann, G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14540 · Cited by 181
Myeloperoxidase attracts neutrophils by physical forces
Klinke, A., Nussbaum, C., Kubala, L., Friedrichs, K., Rudolph, T. K., Rudolph, V., Paust, H.-J., Schröder, C., Benten, D., Lau, D., et al. (2011) · Blood · doi:10.1182/blood-2010-05-284513 · Cited by 179
Biased signalling and proteinase‐activated receptors (PAR s): targeting inflammatory disease
Hollenberg, M. D., Mihara, K., Polley, D., Suen, J. Y., Han, A., Fairlie, D. P., & Ramachandran, R. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12544 · Cited by 176
Nonsteroidal antiinflammatory drugs and uncoupling of mitochondrial oxidative phosphorylation
Mahmud, T., Rafi, S. S., Scott, D. L., Wrigglesworth, J. M., & Bjarnason, I. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391208 · Cited by 175
Advances in the Medical Treatment of Rheumatoid Arthritis
Kahlenberg, J. M., & Fox, D. A. (2011) · Hand Clinics · doi:10.1016/j.hcl.2010.09.002 · Cited by 174
Cohen, S., Radominski, S. C., Gomez‐Reino, J. J., Wang, L., Krishnaswami, S., Wood, S. P., Soma, K., Nduaka, C. I., Kwok, K., Valdez, H., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38779 · Cited by 173
Human neutrophils in auto-immunity
Thieblemont, N., Wright, H. L., Edwards, S. W., & Witko-Sarsat, V. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.03.004 · Cited by 173
A Novel Therapy of Murine Collagen-Induced Arthritis with Soluble T1/ST2
Leung, B. P., Xu, D., Culshaw, S., McInnes, I. B., & Liew, F. Y. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.145 · Cited by 168
Dewas, C., Dang, P. M.-C., Gougerot-Pocidalo, M.-A., & El-Benna, J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.8.4392 · Cited by 163
NETosis as Source of Autoantigens in Rheumatoid Arthritis
Corsiero, E., Pratesi, F., Prediletto, E., Bombardieri, M., & Migliorini, P. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00485 · Cited by 163
Díaz-González, F., González-Alvaro, I., Campanero, M. R., Mollinedo, F., del Pozo, M. A., Muñoz, C., Pivel, J. P., & Sánchez-Madrid, F. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117853 · Cited by 159
Tanaka, D., Kagari, T., Doi, H., & Shimozato, T. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02424.x · Cited by 156
Glucocorticoid Receptor Regulates Expression of L-Selectin and CD11/CD18 on Human Neutrophils
Filep, J. G., Delalandre, A., Payette, Y., & Földes-Filep, E. (1997) · Circulation · doi:10.1161/01.cir.96.1.295 · Cited by 153
Odobasic, D., Kitching, A. R., Yang, Y., O’Sullivan, K. M., Muljadi, R. C. M., Edgtton, K. L., Tan, D. S. Y., Summers, S. A., Morand, E. F., & Holdsworth, S. R. (2013) · Blood · doi:10.1182/blood-2012-09-456483 · Cited by 153
Fujishima, S., Hoffman, A. R., Vu, T., Kim, K. J., Zheng, H., Daniel, D., Kim, Y., Wallace, E. F., Larrick, J. W., & Raffin, T. A. (1993) · Journal of Cellular Physiology · doi:10.1002/jcp.1041540305 · Cited by 151
Coelho, F. M., Pinho, V., Amaral, F. A., Sachs, D., Costa, V. V., Rodrigues, D. H., Vieira, A. T., Silva, T. A., Souza, D. G., Bertini, R., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23622 · Cited by 151
Neutrophils orchestrate their own recruitment in murine arthritis through C5aR and FcγR signaling
Sadik, C. D., Kim, N. D., Iwakura, Y., & Luster, A. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213797109 · Cited by 146
Pérez‐Sánchez, C., Ruiz‐Limón, P., Aguirre, M. A., Jiménez, Y., de la Rosa, I. A., Ábalos‐Aguilera, M. C., Rodríguez‐Ariza, A., Castro, C., Castro, R. O., Segui, P., et al. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.04.007 · Cited by 134
Self-citationRuiz‐Limón, P., Ortega, R., de la Rosa, I. A., Abalos-Aguilera, M. D. C., Pérez‐Sánchez, C., Jiménez, Y., Peralbo‐Santaella, E., Font, P., Ruiz, D., Ferrín, G., et al. (2016) · Translational research · doi:10.1016/j.trsl.2016.12.003 · Cited by 128
Self-citationSynovial fluid leukocyte apoptosis is inhibited in patients with very early rheumatoid arthritis
Raza, K., Scheel‐Toellner, D., Lee, C.-Y., Pilling, D., Curnow, J., Falciani, F., Treviño, V., Kumar, K., Assi, L. K., Lord, J. M., et al. (2006) · Arthritis Research & Therapy · doi:10.1186/ar2009 · Cited by 125
Citrullination of Histone H3 Interferes with HP1-Mediated Transcriptional Repression
Sharma, P., Azébi, S., England, P., Christensen, T., Møller-Larsen, A., Petersen, T., Batsché, É., & Muchardt, C. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002934 · Cited by 115
Talbot, J., Bianchini, F. J., Dcb., N., de Oliveira, R. D. R., Souto, F. O., Pinto, L. G., Peres, R. S., Silva, D., Almeida, S. C. L., Louzada‐Júnior, P., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39117 · Cited by 114
Willis, V. C., Banda, N. K., Cordova, K. N., Chandra, P. E., Robinson, W. H., Cooper, D. C., Lugo, D., Mehta, G., Taylor, S., Tak, P. P., et al. (2017) · Clinical & Experimental Immunology · doi:10.1111/cei.12932 · Cited by 111
Shao, W.-H., Prete, A. D., Bock, C. B., & Haribabu, B. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.6254 · Cited by 109
Cherwinski, H. M., McCarley, D. L., Schatzman, R. C., Devens, B. H., & Ransom, J. T. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24292-6 · Cited by 109
Grespan, R., Fukada, S. Y., Lemos, H. P., Vieira, S. M., Napimoga, M. H., Teixeira, M. M., Fraser, A. R., Liew, F. Y., McInnes, I. B., & Cunha, F. Q. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23597 · Cited by 108
Kawalkowska, J. Z., Quirke, A., Ghari, F., Davis, S. A., Subramanian, V., Thompson, P. R., Williams, R. O., Fischer, R., Thangue, N. B. L., & Venables, P. J. (2016) · Scientific Reports · doi:10.1038/srep26430 · Cited by 104
Cross, A. L., Moots, R. J., & Edwards, S. W. (2007) · Blood · doi:10.1182/blood-2007-05-087833 · Cited by 103
Sperling, R. I., Benincaso, A. I., Anderson, R. J., Coblyn, J. S., Austen, K. F., & Weinblatt, M. E. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350403 · Cited by 97
Blockade of the chemokine receptor CXCR2 ameliorates adjuvant‐induced arthritis in rats
Barsante, M. M., Cunha, T. M., Allegretti, M., Cattani, F., Policani, F., Bizzarri, C., Tafuri, W. L., Poole, S., Cunha, F. Q., Bertini, R., et al. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707462 · Cited by 96
Neutrophil apoptosis in rheumatoid arthritis is regulated by local oxygen tensions within joints
Cross, A. L., Barnes, T. C., Bucknall, R. C., Edwards, S. W., & Moots, R. J. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306178 · Cited by 96
Effects of leflunomide on immune responses and models of inflammation
Bartlett, R. R., Anagnostopulos, H., Zielinski, T. K., Mattar, T., & Schleyerbach, R. (1993) · Springer Seminars in Immunopathology · doi:10.1007/bf00192310 · Cited by 93
Zileuton, a 5-lipoxygenase inhibitor in rheumatoid arthritis.
Weinblatt, M. E., Jm, K., Js, C., Helfgott, S. M., Al, M., Petrillo, G. F., Henson, B. A. B., Rubin, P. D., & Sperling, R. I. (1992) · PubMed · Cited by 92
Seri, Y., Shoda, H., Suzuki, A., Matsumoto, I., Sumida, T., Fujio, K., & Yamamoto, K. (2015) · Scientific Reports · doi:10.1038/srep13041 · Cited by 86
Bilger, A., Plowshay, J., Ma, S., Nawandar, D. M., Barlow, E. A., Romero-Masters, J. C., Bristol, J. A., Li, Z., Tsai, M., Delecluse, H., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17863 · Cited by 86
In Vitro Metabolism of 2-Acetylbenzothiophene: Relevance to Zileuton Hepatotoxicity
Joshi, E. M., Heasley, B. H., Chordia, M. D., & Macdonald, T. L. (2004) · Chemical Research in Toxicology · doi:10.1021/tx0341409 · Cited by 85
Wittkowski, H., Foell, D., af Klint, E., Rycke, L. D., Keyser, F. D., Frosch, M., Ulfgren, A. ‐., & Roth, J. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.061507 · Cited by 85
Muley, M. M., Reid, A. R., Botz, B., Bölcskei, K., Helyes, Z., & McDougall, J. J. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13237 · Cited by 84
Endogenous Myeloperoxidase Is a Mediator of Joint Inflammation and Damage in Experimental Arthritis
Odobasic, D., Yang, Y. H., Muljadi, R. C. M., O’Sullivan, K. M., Kao, W., Smith, M., Morand, E. F., & Holdsworth, S. R. (2013) · Arthritis & Rheumatology · doi:10.1002/art.38299 · Cited by 83
Moots, R. J., Sebba, A., Rigby, W., Ostor, A., Porter-Brown, B., Donaldson, F., Dimonaco, S., Rubbert-Roth, A., van Vollenhoven, R., & Genovese, M. C. (2016) · Rheumatology · doi:10.1093/rheumatology/kew370 · Cited by 82
Multi-antibody composition in lupus nephritis: Isotype and antigen specificity make the difference
Bonanni, A., Vaglio, A., Bruschi, M., Sinico, R. A., Cavagna, L., Moroni, G. L., Franceschini, F., Allegri, L., Pratesi, F., Migliorini, P., et al. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.04.004 · Cited by 80
5-Lipoxygenase Inhibitors Attenuate TNF-α-Induced Inflammation in Human Synovial Fibroblasts
Lin, H., Lin, T., Wu, M., Chiu, Y., Tang, C., Hour, M., Liou, H., Tu, H., Yang, R., & Fu, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107890 · Cited by 78
In vitro and in vivo antitumor activity of a novel immunomodulatory drug, leflunomide
Xu, X., Shen, J., Mall, J. W., Myers, J. A., Huang, W., Blinder, L., Saclarides, T. J., Williams, J. W., & Chong, A. S. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00228-2 · Cited by 76
Citrullination-acetylation interplay guides E2F-1 activity during the inflammatory response
Ghari, F., Quirke, A., Munro, S., Kawalkowska, J. Z., Picaud, S., McGouran, J. F., Subramanian, V., Muth, A., Williams, R. O., Kessler, B. M., et al. (2016) · Science Advances · doi:10.1126/sciadv.1501257 · Cited by 75
Stankovic, A., Slavić, V., Stamenkovic, B. N., Kamenov, B., Bojanovic, M., & Mitrovic, D. R. (2009) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/bf03657240 · Cited by 75
Leflunomide: A Drug with a Potential Beyond Rheumatology
Teschner, S., & Burst, V. R. (2010) · Immunotherapy · doi:10.2217/imt.10.52 · Cited by 74
Activation mechanisms of adherent human neutrophils
Ginis, I., & Tauber, A. (1990) · Blood · doi:10.1182/blood.v76.6.1233.bloodjournal7661233 · Cited by 73
Inhibition of leukocyte adhesion: an alternative mechanism of action for anti-inflammatory drugs
Díaz‐González, F., & Sánchez‐Madrid, F. (1998) · Immunology Today · doi:10.1016/s0167-5699(97)01216-4 · Cited by 73
Neutrophils produce interleukin-17B in rheumatoid synovial tissue
Kouri, V., Olkkonen, J., Ainola, M., Li, T.-F., Björkman, L. I., Konttinen, Y. T., & Mandelin, J. (2013) · Rheumatology · doi:10.1093/rheumatology/ket309 · Cited by 72
Suzuki, A., Kochi, Y., Shoda, H., Seri, Y., Fujio, K., Sawada, T., Yamada, R., & Yamamoto, K. (2016) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-016-1055-2 · Cited by 72
Effects of glucocorticoids on apoptosis of infiltrated eosinophils and neutrophils in rats
Nittoh, T., Fujimori, H., Kozumi, Y., Ishihara, K., Mue, S., & Ohuchi, K. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00426-9 · Cited by 70
den Broeder, A. A., Wanten, G. J. A., Oyen, W. J. G., Naber, A. H. J., van Riel, P. L. C. M., & Barrera, P. (2003) · PubMed · Cited by 69
Evaluation of protease‐activated receptor 2 in murine models of arthritis
Busso, N., Frasnelli, M. E., Feifel, R., Cenni, B., Steinhoff, M. S., Hamilton, J. R., & So, A. K.-L. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22312 · Cited by 68
Zhu, X., Xiao, L., Huo, R., Zhang, J., Lin, J., Xie, J., Sun, S., He, Y., Sun, Y., Zhou, Z., et al. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4377 · Cited by 67
Min, S. H., Wang, Y., Gonsiorek, W., Anilkumar, G., Kozlowski, J. A., Lundell, D. J., Fine, J. S., & Grant, E. P. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.025 · Cited by 64
Increased myeloperoxidase plasma levels in rheumatoid arthritis
Fernandes, R. M. S. N., da Silva, N. P., & Sato, E. I. (2011) · Rheumatology International · doi:10.1007/s00296-011-1810-5 · Cited by 62
Barbarroja, N., Pérez‐Sánchez, C., Ruiz‐Limón, P., Castro, C., Aguirre, M. A., Carretero, R. M., Segui, P., Jiménez, Y., Sanna, M., Rodríguez‐Ariza, A., et al. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304475 · Cited by 62
Self-citationLlewellyn-Jones, C. G., Hill, S. L., & Stockley, R. A. (1994) · Thorax · doi:10.1136/thx.49.3.207 · Cited by 58
Pro-inflammatory properties and neutrophil activation by Helicobacter pylori urease
Uberti, A. F., Olivera‐Severo, D., Wassermann, G. E., Guerra, A. S., Moraes, J. A., Barcellos‐de‐Souza, P., Barja‐Fidalgo, C., & Carlini, C. R. (2013) · Toxicon · doi:10.1016/j.toxicon.2013.02.009 · Cited by 57
Mitchell, T., Moots, R. J., & Wright, H. L. (2017) · Clinical & Experimental Immunology · doi:10.1111/cei.12970 · Cited by 55
Sodium Salicylate Promotes Neutrophil Apoptosis by Stimulating Caspase-Dependent Turnover of Mcl-1
Derouet, M. F., Thomas, L. W., MOULDING, D. A., Akgul, C., Cross, A. L., Moots, R. J., & Edwards, S. W. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.2.957 · Cited by 53
Gómez‐Gaviro, M. V., González‐Álvaro, I., Domı́nguez-Jiménez, C., Peschon, J. J., Black, R. A., Sánchez‐Madrid, F., & Díaz‐González, F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205142200 · Cited by 50
Effects of tocilizumab on neutrophil function and kinetics
Lok, L. S. C., Farahi, N., Juss, J. K., Loutsios, C., Solanki, C. K., Peters, A. M., Donaldson, F., Porter-Brown, B., & Chilvers, E. R. (2017) · European Journal of Clinical Investigation · doi:10.1111/eci.12799 · Cited by 50
Masferrer, J. L., Zweifel, B. S., Hardy, M. M., Anderson, G. D., Dufield, D. R., Cortes-Burgos, L. A., Pufahl, R. A., & Graneto, M. J. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.166967 · Cited by 48
Inhibition of neutrophil chemotaxis in methotrexate-treated rheumatoid arthritis patients
O'Callaghan, J. P., Forrest, M. J., & Brooks, P. (1988) · Rheumatology International · doi:10.1007/bf00541349 · Cited by 43
Shovman, O., Shoenfeld, Y., & Langevitz, P. (2014) · Immunologic Research · doi:10.1007/s12026-014-8590-4 · Cited by 42
Ottonello, L. C., Frumento, G., Arduino, N., Bertolotto, M. B., MANCINI, M., Sottofattori, E., Dallegri, F., & Cutolo, M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04219.x · Cited by 40
Awni, W. M., Braeckman, R. A., Granneman, G. R., Witt, G. F., & Dubé, L. M. (1995) · Clinical Pharmacokinetics · doi:10.2165/00003088-199500292-00005 · Cited by 40
Dominical, V. M., Bértolo, M. B., Almeida, C. B., Garrido, V. T., Miguel, L. I., Costa, F. F., & Conran, N. (2011) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2011.02503.x · Cited by 37
Jang, B., Kim, H. W., Kim, J.-S., Kim, W. S., Lee, B. R., Kim, S., Kim, H., Han, S. J., Ha, S., & Shin, S. J. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0314-142rr · Cited by 34
Genetic variation at the CCR5/CCR2 gene cluster and risk of psoriasis and psoriatic arthritis
Soto‐Sánchez, J., Santos‐Juanes, J., Coto‐Segura, P., Coto, E., Díaz, M., Rodríguez, I., & Álvarez, V. (2010) · Cytokine · doi:10.1016/j.cyto.2010.01.006 · Cited by 32
Barcellos‐de‐Souza, P., Canetti, C. D. A., Barja‐Fidalgo, C., & Arruda, M. A. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.07.012 · Cited by 31
Leflunomide in renal transplantation
Chon, W. J., & Josephson, M. A. (2011) · Expert Review of Clinical Immunology · doi:10.1586/eci.11.20 · Cited by 31
Leflunomide therapy for BK virus allograft nephropathy after pediatric kidney transplantation
Jung, Y. H., Moon, K. C., Ha, J., Kim, S., Ha, I. S., Cheong, H. I., & Kang, H. G. (2012) · Pediatric Transplantation · doi:10.1111/petr.12029 · Cited by 30
Disentangling the effects of tocilizumab on neutrophil survival and function
Gaber, T., Hahne, M., Strehl, C., Hoff, P., Dörffel, Y., Feist, E., Burmester, G. R., & Buttgereit, F. (2015) · Immunologic Research · doi:10.1007/s12026-015-8770-x · Cited by 15
Šenolt, L., Prajzlerová, K., Hulejová, H., Šumová, B., Filková, M., Veigl, D., Pavelká, K., & Vencovský, J. (2017) · Cytokine · doi:10.1016/j.cyto.2017.06.009 · Cited by 14
Zielinski, T., Müller, H.-J., Schleyerbach, R., & Bartlett, R. R. (1994) · Inflammation Research · doi:10.1007/bf01987668 · Cited by 13
Prostanoid Biology and Its Therapeutic Targeting
Crofford, L. J. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-1738-9.00059-1 · Cited by 8
Cited by
Quercetin alleviates rheumatoid arthritis by inhibiting neutrophil inflammatory activities
Yuan, K., Zhu, Q., Lu, Q., Jiang, H., Zhu, M., Li, X., Huang, G., & Xu, A. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108454 · Cited by 177
Metadata
- Authors
- Cecchi, I., Arias de la Rosa, I., Menegatti, E., Roccatello, D., Collantes-Estevez, E., Lopez-Pedrera, C., & Barbarroja, N.
- Venue
- Autoimmunity Reviews
- Publisher
- Elsevier BV
- Published
- 2018-11
- Volume
- 17
- Issue
- 11
- Pages
- 1138-1149
- ISSN
- 1568-9972 (ISSN-L)
- OpenAlex
- W2890608919
- Cited by
- 169
- References
- 141
- FWCI
- 11.74
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.